Physician profile
Kenneth Blue
NPI 1154382083
$4,275.44
in general payments reported to CMS, 2019-2025
39 companies · $116 in 2025
The $116 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $917 · 2020: $199 · 2021: $410 · 2022: $494 · 2023: $1,167 · 2024: $973 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,256.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $841.93 | 2019-2024 | Xtandi, Myrbetriq |
| Abbvie INC. | $517.72 | 2019-2025 | Botox, Lupron Depot, Ubrelvy |
| Sumitomo Pharma America, INC. | $496.51 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $304.65 | 2019-2023 | |
| Allergan, INC. | $269.77 | 2019-2022 | |
| Urogen Pharma, INC. | $236.36 | 2021-2025 | Jelmyto |
| Femselect INC. | $230.00 | 2023 | Enplace |
| Dendreon Pharmaceuticals LLC | $187.24 | 2023-2024 | Provenge |
| Myriad Genetic Laboratories, INC. | $136.52 | 2023 | Prolaris |
| Blue Earth Diagnostics | $129.94 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.64 | 2019-2022 | |
| Myovant Sciences INC. | $81.71 | 2021-2022 | |
| Antares Pharma, INC. | $73.93 | 2019-2024 | Xyosted |
| Urovant Sciences INC | $67.09 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $59.99 | 2023-2024 | Pylarify |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $50.77 | 2023-2024 | |
| Accord Healthcare, INC. | $49.86 | 2023-2024 | |
| Pfizer INC. | $39.29 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $38.30 | 2019 | |
| Rochester Medical Corporation | $37.72 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $26.48 | 2024 | |
| 180 Medical, INC. | $25.12 | 2023 | Cure Catheter |
| Civco Medical Instruments | $22.86 | 2024 | |
| Procept Biorobotics Corporation | $20.99 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.99 | 2024 | Soliris |
| Agiliti Surgical, INC. | $19.65 | 2019 | |
| Ambu INC. | $18.53 | 2022 | |
| Immunitybio, INC. | $18.21 | 2024 | |
| Merz North America, INC. | $17.78 | 2024 | |
| Halozyme INC | $17.75 | 2023 | |
| Ferring Pharmaceuticals INC. | $17.60 | 2024 | Adstiladrin |
| Neotract INC. | $17.59 | 2019 | |
| Mission Pharmacal Company | $17.00 | 2022 | |
| Verity Pharmaceuticals INC. | $15.98 | 2024 | Trelstar |
| Astrazeneca Pharmaceuticals Lp | $15.76 | 2022 | |
| Tolmar, INC. | $15.71 | 2023 | |
| Clarus Therapeutics INC. | $12.94 | 2021 | |
| Ethicon US, LLC | $11.82 | 2020 | |
| Medtronic, INC. | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Blue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.